Holzer Holzer & Fistel, LLC is investigating whether the directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE: HS) complied with their fiduciary duties in approving the proposed acquisition of the Company by Cigna Corporation. According to the Company’s announcement, if the deal closes HeathSpring shareholders will receive $55.00 per share of HS owned. The investigation seeks to determine, among other things, whether the consideration to be paid to HealthSpring shareholders is fair and adequate. Current holders of HealthSpring common stock with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at firstname.lastname@example.org, or email@example.com, or via toll-free telephone at 888-508-6832. Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.
Healthspring (NYSE:HS) hit a new 52-week high Friday as it is currently trading at $54.94, above its previous 52-week high of $54.91 with 84,727 shares traded as of 9:35 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.
Healthspring (NYSE:HS) hit a new 52-week high Tuesday as it is currently trading at $54.50, above its previous 52-week high of $54.46 with 1.5 million shares traded as of 2:46 p.m. ET. Average volume has been 1.7 million shares over the past 30 days.